REFERENCES
- Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, et al. Clinical features of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;121:284–290.
- Biglan AW. Control of eyelid retraction associated with Graves’ disease with botulinum A toxin. Ophthalmic Surg. 1994;25:186–188.
- Burns CL, Gammon JA, Gemmill MC. Ptosis associated with botulinum toxin treatment of strabismus and blepharospasm. Ophthalmology. 1986;93:1621–1627.
- Ebner R. Botulinum toxin type A in upper lid retraction of Graves’ ophthalmopathy. J Clin Neuro-ophthalmol. 1993;13:258–261.
- Elston JS. The management of blepharospasm and hemi facial spasm. J Neurol. 1992;239:5–8.
- Gay AJ, Wolkstein MA. Topical guanethidine therapy for endocrine lid retraction. Arch Ophthalmol. 1966;76:364–367.
- Grove AS Jr (1981): Upper eyelid retraction and Graves’ disease. Ophthalmology. 1981;88:499–506.
- Hedin A. Eyelid surgery in dysthyroid ophthalmopathy. Eye. 1988;2:201–206.
- Heyworth PLO, Lee JP. Persisting hypotropias following protective ptosis induced by botulinum neurotoxin. Eye. 1994;8:511–514.
- Kirkness CM, Adams GG, Dilly PN, Lee JP. Botulinum toxin A- induced protective ptosis in corneal disease. Ophthalmology. 1988;95:473–480.
- Lee J, Elston J, Vickers S, et al. Botulinum toxin therapy for squint. Eye. 1988;2:24–28.
- Lee J, Harris S, Cohen J, et al. Results of a prospective randomized trial of botulinum toxin therapy in acute unilateral sixth nerve palsy. J Pediatr Ophthalmol Strabismus. 1994;31:283–286.
- Ozkan SB, Can D, Soylev MF, Arsan AK, Duman S. Chemodenervation in treatment of upper eyelid retraction. Ophthalmologica. 1997;211:387–390.
- Repka MX, Savino PJ, Reinecke RD. Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophthalmol. 1994;112:1320–1324.
- Riordan–Eva P, Lee JP. Management of VIth nerve palsy avoiding unnecessary surgery. Eye. 1992;6:386–390.
- Rosales RL, Bigalke H, Dressler D.Pharmacology of Botulinum toxin: differences between type A preparations. Eur J Neurol. 2006 Feb; 13 Suppl 1:2–10.
- Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol. 1973;12:224–227.
- Shih MJ, Liao SL, Lu HY. A single transcutaneous injection with Botox for dysthyroid lid retraction. Eye. 2004;18:466–469.
- Steel DH, Hoh HB, Harrad RA, Collins CR. Botulinum toxin for the temporary treatment of involutional lower lid entropion: A clinical and morphological study. Eye. 1997;11:472–475.
- Uddin JM, Davies PD. Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection. Ophthalmology. 2002;109:1183–1187.